5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1) (93940-86-4)

Other Product

• (1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
• [7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
• 5-oxo-L-proline, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)
• [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with α-phenylbenzylamine
• methyl (3α,14β,16α)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylate, compound with 5-oxo-L-proline (1:1)
• (1α,3α,4α,5β)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid, compound with 4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzenemethanol (1:1)
• [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with 1-ethylpiperidine (1:1)
• methyl (16β,17α,20α)-17-hydroxyyohimban-16-carboxylate , compound with 5-oxo-L-proline (1:1)
• [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with dibenzylamine
• l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• (4α,8α,9β,13α,14β,17Z)-16β-acetoxy-3α,11α-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, compound with 2,2'-iminodiethanol (1:1)
• (1α,3aβ,4α,7α,8aβ)-hexahydro-1,4,10,10-tetramethyl-1H,4H,3a,8a-epoxy-4,7-methanoazulene
• S-(carboxymethyl)-L-cysteine [2S-[2α,5α,6β(S*)]]-6-[(aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate, disodium salt
• 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2α,5α,6β)]-, compd. with [R-(R*,S*)]-β-(methylamino)-α-phenylbenzeneethanol (1:1)
• 5-oxo-L-proline, compound with [2R-[2α,6α(S*)]]-2-[6-(β-hydroxyphenethyl)-1-methyl-2-piperidyl]acetophenone (1:1)
• l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• Yohimban-16-carboxylic acid, 1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3β,16β,17α,18β,20α)-, compd. with 5-oxo-l-proline (1:2)
• 5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine
• Acetic acid, [[2-(diethylamino)ethyl]thio]-, 6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo-3a,9-propano-3aH-cyclopentacycloocten-8-yl ester, [3aS-(3aα,4β,5α,6α,8β,9α,9aβ,10S*)]-, (E)-2-butenedioate (2:1)
• (1α,2β,4β,6α)-()-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane